Michelle T. Long - Concepedia

Author

Michelle T. Long

Also Known As

C Bliss, Douglas Loesch, Long, Michelle T., M LONG, M Long, M. Long, M.T. Long, MICHELLE T. LONG, Michelle J. Long, Michelle Long

209

Publications

7.6K

Citations

H-Index

194

Concepts

All Affiliations

Boston University Harvard University Massachusetts General Hospital Boston Medical Center National Heart Lung and Blood Institute

About

Michelle T. Long is an author at Boston University specializing in medicine, health sciences, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	30	3.4K
2	Health Sciences	18	23	2K
3	Education	2	2	94
4	Arts	1	1	17
5	Language Studies	1	1	17

Michelle T. Long

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis Philip N. Newsome, Iris Kliers, Laura Østergaard, New England Journal of Medicine	2025	398
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review Michelle T. Long, Mazen Noureddin, Joseph K. Lim Gastroenterology ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver Disease	2022	251
Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement Hannes Hagström, Leon A. Adams, Alina M. Allen, Hepatology	2021	231
Bi-directional analysis between fatty liver and cardiovascular disease risk factors Jiantao Ma, Shih‐Jen Hwang, Alison Pedley, Journal of Hepatology HyperlipidemiaFatty Liver DiseaseObesityMetabolic SyndromeBody Composition	2016	227
Elevated snoRNA biogenesis is essential in breast cancer Hang Su, Suthakar Ganapathy, Miriam Shadfan, Oncogene Tumor BiologyBreast OncologySnorna BiogenesisMedicinePathology	2013	202
Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease Jiantao Ma, Rachel Hennein, Chunyu Liu, Gastroenterology ObesityMetabolic SyndromeNutritionHepatologyNonalcoholic Fatty Liver Disease	2018	182
Clonal haematopoiesis and risk of chronic liver disease Waihay J. Wong, Connor A. Emdin, Alexander G. Bick, Nature HepatologyLiver PhysiologyImmunologyHematologyHepatitis	2023	182
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation Marijana Vujković, Shweta Ramdas, Kimberly Lorenz, Nature Genetics Genome-wide Association StudyMetabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver Disease	2022	179
Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis Michelle T. Long, Alison Pedley, Lisandro D. Colantonio, Clinical Gastroenterology and Hepatology Metabolic Associated SteatohepatitisFramingham Steatosis IndexHepatologyLiver PhysiologyClinical Epidemiology	2016	148

Page 1